Circadian variation in plasma levels of free-form tissue factor pathway inhibitor antigen in patients with coronary spastic angina

Jpn Circ J. 1998 Jun;62(6):419-24. doi: 10.1253/jcj.62.419.

Abstract

Tissue factor pathway inhibitor (TFPI) is known to inhibit the initial reaction in the tissue factor-mediated coagulation pathway. We measured plasma free-form TFPI antigen levels and monitored 24-h Holter recordings at 06.00, 14.00 and 22.00 h in 15 patients with coronary spastic angina, 13 patients with stable exertional angina, and 11 control subjects. There was a significant circadian variation in plasma free-form TFPI antigen levels in patients with coronary spastic angina (25.8+/-2.0 ng/ml at 06.00 h, 21.1+/-1.6 ng/ml at 14.00 h, and 20.2+/-1.4 ng/ml at 22.00 h; p<0.01). Furthermore, free-form TFPI antigen levels at 06.00 h were significantly higher in coronary spastic angina patients than in patients with stable exertional angina or control subjects (p<0.01). Free-form TFPI antigen levels increased after the ischemic attacks in coronary spastic angina (p<0.01). This circadian variation correlated with the frequency of attacks, with the peak level occurring between midnight to early morning in patients with coronary spastic angina.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Angina Pectoris / blood
  • Angina Pectoris / epidemiology
  • Angina Pectoris / physiopathology
  • Angina, Unstable / blood*
  • Angina, Unstable / epidemiology
  • Angina, Unstable / physiopathology
  • Cardiac Catheterization
  • Circadian Rhythm*
  • Coronary Angiography
  • Coronary Vasospasm / blood*
  • Coronary Vasospasm / epidemiology
  • Coronary Vasospasm / physiopathology
  • Endothelium, Vascular / metabolism*
  • Female
  • Humans
  • Lipoproteins / blood*
  • Male
  • Middle Aged
  • Physical Exertion
  • Risk Factors
  • Secretory Rate

Substances

  • Lipoproteins
  • lipoprotein-associated coagulation inhibitor